We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 5th:
Emerald Holding, Inc. (EEX - Free Report) : This operator of business-to-business trade shows has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.
Emerald Expositions Events, Inc. Price and Consensus
GAIN Capital Holdings, Inc. : This provider of trading services and solutions has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.
Banco BBVA Argentina S.A. (BBAR - Free Report) : This provider of various banking products and services has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.8% over the last 60 days.
The Allstate Corporation (ALL - Free Report) : This provider of property and casualty and other insurance products has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 5.2% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Value Stocks to Buy for May 5th
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 5th:
Emerald Holding, Inc. (EEX - Free Report) : This operator of business-to-business trade shows has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.
Emerald Expositions Events, Inc. Price and Consensus
Emerald Expositions Events, Inc. price-consensus-chart | Emerald Expositions Events, Inc. Quote
Emerald has a price-to-earnings ratio (P/E) of 2.32, compared with 15.60 for the industry. The company possesses a Value Score of A.
Emerald Expositions Events, Inc. PE Ratio (TTM)
Emerald Expositions Events, Inc. pe-ratio-ttm | Emerald Expositions Events, Inc. Quote
GAIN Capital Holdings, Inc. : This provider of trading services and solutions has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.
GAIN Capital Holdings, Inc. Price and Consensus
GAIN Capital Holdings, Inc. price-consensus-chart | GAIN Capital Holdings, Inc. Quote
GAIN Capital has a price-to-earnings ratio (P/E) of 2.42, compared with 13.10 for the industry. The company possesses a Value Score of B.
GAIN Capital Holdings, Inc. PE Ratio (TTM)
GAIN Capital Holdings, Inc. pe-ratio-ttm | GAIN Capital Holdings, Inc. Quote
Banco BBVA Argentina S.A. (BBAR - Free Report) : This provider of various banking products and services has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.8% over the last 60 days.
BBVA Banco Frances S.A. Price and Consensus
BBVA Banco Frances S.A. price-consensus-chart | BBVA Banco Frances S.A. Quote
Banco BBVA Argentina has a price-to-earnings ratio (P/E) of 1.57, compared with 11.60 for the industry. The company possesses a Value Score of A.
BBVA Banco Frances S.A. PE Ratio (TTM)
BBVA Banco Frances S.A. pe-ratio-ttm | BBVA Banco Frances S.A. Quote
The Allstate Corporation (ALL - Free Report) : This provider of property and casualty and other insurance products has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 5.2% over the last 60 days.
The Allstate Corporation Price and Consensus
The Allstate Corporation price-consensus-chart | The Allstate Corporation Quote
Allstate has a price-to-earnings ratio (P/E) of 9.19, compared with 10.70 for the industry. The company possesses a Value Score of A.
The Allstate Corporation PE Ratio (TTM)
The Allstate Corporation pe-ratio-ttm | The Allstate Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>